Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion description "[Altogether, the current generation of somatostatin analogs are effective medical tools in the treatment of acromegalic patients and of patients with neuroendocrine GEP tumors, but there is certainly a need for novel somatostatin analogs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion evidence source_evidence_literature NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion SIO_000772 16625843 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion wasDerivedFrom befree-2016 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion wasGeneratedBy ECO_0000203 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- befree-2016 importedOn "2016-02-19" NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.